questionsmedicales.fr
Virus
Virus à ARN
Retroviridae
Lentivirus
Lentivirus ovins-caprins
Virus maedi-visna
Virus maedi-visna : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus maedi-visna : Questions médicales les plus fréquentes",
"headline": "Virus maedi-visna : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus maedi-visna : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-20",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus maedi-visna"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lentivirus ovins-caprins",
"url": "https://questionsmedicales.fr/mesh/D017972",
"about": {
"@type": "MedicalCondition",
"name": "Lentivirus ovins-caprins",
"code": {
"@type": "MedicalCode",
"code": "D017972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.650.589.600"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus maedi-visna",
"alternateName": "Visna-maedi virus",
"code": {
"@type": "MedicalCode",
"code": "D014790",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xujie Duan",
"url": "https://questionsmedicales.fr/author/Xujie%20Duan",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Xiaona Shi",
"url": "https://questionsmedicales.fr/author/Xiaona%20Shi",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Shuying Liu",
"url": "https://questionsmedicales.fr/author/Shuying%20Liu",
"affiliation": {
"@type": "Organization",
"name": "College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China."
}
},
{
"@type": "Person",
"name": "Stefán R Jónsson",
"url": "https://questionsmedicales.fr/author/Stef%C3%A1n%20R%20J%C3%B3nsson",
"affiliation": {
"@type": "Organization",
"name": "Institute for Experimental Pathology, University of Iceland, Keldur, Reykjavik 112, Iceland."
}
},
{
"@type": "Person",
"name": "Yalçın Yaman",
"url": "https://questionsmedicales.fr/author/Yal%C3%A7%C4%B1n%20Yaman",
"affiliation": {
"@type": "Organization",
"name": "Siirt University Faculty of Veterinary Medicine, Department of Genetics, Siirt, Türkiye."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Bioactive Vitamin D Attenuates MED28-Mediated Cell Growth and Epithelial-Mesenchymal Transition in Human Colorectal Cancer Cells.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36072467",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/2268818"
}
},
{
"@type": "ScholarlyArticle",
"name": "Developing a prognostic model for hepatocellular carcinoma based on MED19 and clinical stage and determining MED19 as a therapeutic target.",
"datePublished": "2024-10-05",
"url": "https://questionsmedicales.fr/article/39369139",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00432-024-05978-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37668348",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1530/JME-23-0039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies.",
"datePublished": "2022-11-22",
"url": "https://questionsmedicales.fr/article/36414996",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13293-022-00477-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Improving antitumor T cells.",
"datePublished": "2022-11-10",
"url": "https://questionsmedicales.fr/article/36356156",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1126/science.adf0546"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Retroviridae",
"item": "https://questionsmedicales.fr/mesh/D012190"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lentivirus",
"item": "https://questionsmedicales.fr/mesh/D016086"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lentivirus ovins-caprins",
"item": "https://questionsmedicales.fr/mesh/D017972"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus maedi-visna",
"item": "https://questionsmedicales.fr/mesh/D014790"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus maedi-visna - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus maedi-visna",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus maedi-visna",
"description": "Comment diagnostiquer une infection par le virus maedi-visna ?\nQuels tests sont utilisés pour le virus maedi-visna ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer le virus chez les animaux asymptomatiques ?\nQuelle est l'importance du diagnostic précoce ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Mediator+Complex&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus maedi-visna",
"description": "Quels sont les symptômes principaux du virus maedi-visna ?\nLes symptômes varient-ils selon l'âge des moutons ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes sont-ils toujours présents ?\nComment évoluent les symptômes au fil du temps ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Mediator+Complex&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus maedi-visna",
"description": "Comment prévenir l'infection par le virus maedi-visna ?\nLes tests de dépistage sont-ils efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nLes animaux doivent-ils être vaccinés ?\nComment gérer les nouveaux animaux dans un troupeau ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Mediator+Complex&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus maedi-visna",
"description": "Quel est le traitement principal pour le virus maedi-visna ?\nPeut-on utiliser des antiviraux contre ce virus ?\nComment gérer les animaux infectés ?\nY a-t-il des vaccins disponibles ?\nQuel rôle joue la nutrition dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Mediator+Complex&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus maedi-visna",
"description": "Quelles complications peuvent survenir avec le virus maedi-visna ?\nLes complications sont-elles fréquentes ?\nComment les complications affectent-elles la production ?\nLes complications sont-elles réversibles ?\nQuel est le pronostic pour les animaux infectés ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Mediator+Complex&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus maedi-visna",
"description": "Quels sont les facteurs de risque d'infection ?\nLe stress augmente-t-il le risque d'infection ?\nLes races de moutons sont-elles affectées différemment ?\nL'environnement joue-t-il un rôle dans l'infection ?\nLes pratiques d'élevage influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014790?mesh_terms=Mediator+Complex&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le virus maedi-visna ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et des analyses PCR pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le virus maedi-visna ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et PCR sont couramment utilisés pour identifier le virus dans le sang."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques comme la pneumonie et l'encéphalite orientent le diagnostic."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer le virus chez les animaux asymptomatiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sérologiques peuvent détecter le virus même sans symptômes visibles."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du diagnostic précoce ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic précoce permet de mieux gérer la maladie et de limiter sa propagation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du virus maedi-visna ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, difficultés respiratoires et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge des moutons ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes animaux peuvent présenter des symptômes plus graves que les adultes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes neurologiques comme des tremblements et des troubles de la coordination peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains animaux peuvent être porteurs sans montrer de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes au fil du temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver progressivement, menant à des complications graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus maedi-visna ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'isolement des animaux infectés et des pratiques d'élevage saines."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier des troupeaux permet de détecter et d'éliminer les animaux infectés."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures d'hygiène strictes, comme le nettoyage des équipements, sont essentielles."
}
},
{
"@type": "Question",
"name": "Les animaux doivent-ils être vaccinés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien qu'il n'y ait pas de vaccin, la vaccination contre d'autres maladies est recommandée."
}
},
{
"@type": "Question",
"name": "Comment gérer les nouveaux animaux dans un troupeau ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nouveaux animaux doivent être testés et mis en quarantaine avant d'intégrer le troupeau."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus maedi-visna ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique; la gestion des symptômes est essentielle."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des antiviraux contre ce virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'y a pas d'antiviraux efficaces spécifiquement pour le virus maedi-visna."
}
},
{
"@type": "Question",
"name": "Comment gérer les animaux infectés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les animaux infectés doivent être isolés et traités symptomatiquement pour améliorer leur confort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de vaccin commercialement disponible contre le virus maedi-visna."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la nutrition dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne nutrition peut aider à renforcer le système immunitaire des animaux infectés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le virus maedi-visna ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent pneumonie chronique et encéphalite, pouvant être mortelles."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications sont courantes chez les animaux infectés, surtout sans traitement."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la production ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la productivité des animaux, affectant la rentabilité de l'élevage."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup sont irréversibles et graves."
}
},
{
"@type": "Question",
"name": "Quel est le pronostic pour les animaux infectés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le pronostic dépend de la gravité des symptômes; beaucoup développent des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le stress, et la densité de population dans le troupeau."
}
},
{
"@type": "Question",
"name": "Le stress augmente-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire, augmentant le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les races de moutons sont-elles affectées différemment ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines races peuvent être plus susceptibles à l'infection en raison de leur génétique."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans l'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un environnement surpeuplé et insalubre favorise la propagation du virus."
}
},
{
"@type": "Question",
"name": "Les pratiques d'élevage influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des pratiques d'élevage inadéquates augmentent le risque de transmission du virus."
}
}
]
}
]
}
Inadequate vitamin D status may increase the risk of developing multiple types of cancer. Epidemiological studies suggest an inverse association between 25-hydroxyvitamin D...
Mediator complex subunit 19 (MED19), a member of the mediator complex, has been demonstrated to involve in tumorigenesis of hepatocellular carcinoma (HCC). However, the regulation mechanisms of MED19,...
Here, we analyzed data from The Cancer Genome Atlas and other databases to assess the expression of MED19 and its prognosis and therapeutical-targets impact in HCC....
MED19 expression was upregulated in HCC tissues compared to non-tumorous liver tissues and that its upregulation was positively associated with advanced clinicopathology features. The multivariate ana...
These findings suggest that MED19 as a novel biomarker that has significant association with immune landscape and immunotherapy response in HCC. The proposed prediction model composed of MED19 and pat...
Uterine fibroids (UFs) are benign tumors arising from the uterus, characterized by accumulation of abundant extracellular matrix (ECM) and sex steroid-dependent growth. Women with symptomatic UFs have...
In recent decades, increasing longevity (among other factors) has fostered a rise in Parkinson's disease incidence. Although not exhaustively studied in this devastating disease, the impact of sex rep...
To study sex bias in Parkinson's disease, we conducted a systematic review to select sex-labeled transcriptomic data from three relevant brain tissues: the frontal cortex, the striatum, and the substa...
The tissue-specific meta-analyses linked Parkinson's disease to the enhanced expression of MED31 in the female frontal cortex and the dysregulation of 237 genes in the substantia nigra. The global met...
Our in silico approach has highlighted sex-based differential mechanisms in typical Parkinson Disease hallmarks (inflammation, mitochondrial dysfunction, and oxidative stress). Additionally, we have i...
Disrupting cell cycle regulators can overcome anticancer T cell dysfunction....
MED12-related disorders represent a spectrum of rare neurodevelopmental disorders causing intellectual disability, dysmorphic features, and other systemic abnormalities. We report a case of a 21-month...
To determine molecular events involved in the tumorigenesis of phyllodes tumors (PT) and the role of each stromal (SC) and epithelial (EC) cell....
Frozen breast samples enriched with epithelial and stromal cells from three fibroadenomas and 14 PT were retrieved and laser microdissected. Sanger and polymerase chain reaction-based sequencing of ex...
All three fibroadenomas (FAs) presented mutations in MED12, but not in TERT, whose mutation was observed in five of the 14 PTs. EC and SC of each affected tumor displayed identical alterations. Of the...
Identical TERT mutations from both SC and ES origins might affect the PTs tumorigenesis. Gene expression differences suggest coordinated molecular processes between these components with determinant d...
Presented are four cystic renal masses which harbored a MED15::TFE3 gene fusion detected by RNAseq, mimicking multilocular cystic neoplasm of low malignant potential. Clinicopathologic and outcomes da...
Gonadotropin-releasing hormone agonists are used to treat premenopausal uterine leiomyomas; however, leiomyoma volume reduction is not always achieved. The reduction rate after this treatment varies f...
This study aimed to determine the predictive use of MED12 mutations for evaluating the effect of gonadotropin-releasing hormone agonist treatment concerning reducing uterine leiomyoma volume and to pr...
MED12 exon 2 mutation and erythropoietin expression in uterine leiomyomas were evaluated concerning volume reduction, as measured using magnetic resonance imaging. We developed a system for classifyin...
Patients with MED12 exon 2 mutations had smaller volume reduction after treatment with the gonadotropin-releasing hormone agonist (P<.001, Mann-Whitney U test) and displayed lower signal intensity on ...
MED12 mutation status can be a candidate marker for predicting the effect of gonadotropin-releasing hormone agonists on uterine leiomyoma reduction. Magnetic resonance imaging findings can be used to ...
Human RSV is the leading cause of infantile bronchiolitis in the world and one of the major causes of childhood deaths in resource-poor settings. It is a major unmet target for vaccines and anti-viral...